Transcode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 Ttx-Mc138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
Transcode Therapeutics宣佈，經過對隊列1安全數據的有利審查後，安全審查委員會批准了Ttx-Mc138臨床試驗第1隊列的第二隊列開放。
